Lilleri D - Search Results

1

Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis.

Bugatti S, De Stefano L, Balduzzi S, Greco MI, Luvaro T, Cassaniti I, Bogliolo L, Mazzucchelli I, D'Onofrio B, di Lernia M, Mauric E, Lilleri D, Baldanti F, Manzo A, Montecucco C. Bugatti S, et al. Among authors: d onofrio b, lilleri d. Ann Rheum Dis. 2021 Dec;80(12):1635-1638. doi: 10.1136/annrheumdis-2021-220862. Epub 2021 Jun 25. Ann Rheum Dis. 2021. PMID: 34172502 No abstract available.

2

Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification.

Gerna G, Baldanti F, Middeldorp JM, Furione M, Zavattoni M, Lilleri D, Revello MG. Gerna G, et al. Among authors: lilleri d. J Clin Microbiol. 1999 Apr;37(4):902-11. doi: 10.1128/JCM.37.4.902-911.1999. J Clin Microbiol. 1999. PMID: 10074499 Free PMC article.

3

Use of CMV transcripts for monitoring of CMV infections in transplant recipients.

Gerna G, Baldanti F, Middeldorp J, Lilleri D. Gerna G, et al. Among authors: lilleri d. Int J Antimicrob Agents. 2000 Dec;16(4):455-60. doi: 10.1016/s0924-8579(00)00279-x. Int J Antimicrob Agents. 2000. PMID: 11118857

4

Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.

Lilleri D, Piccinini G, Baldanti F, Seminari E, Galloni D, Gerna G. Lilleri D, et al. J Clin Virol. 2003 Jan;26(1):95-100. doi: 10.1016/s1386-6532(02)00044-6. J Clin Virol. 2003. PMID: 12589839

5

Human cytomegalovirus pp67 mRNAemia versus pp65 antigenemia for guiding preemptive therapy in heart and lung transplant recipients: a prospective, randomized, controlled, open-label trial.

Gerna G, Baldanti F, Lilleri D, Parea M, Torsellini M, Castiglioni B, Vitulo P, Pellegrini C, Viganò M, Grossi P, Revello MG. Gerna G, et al. Among authors: lilleri d. Transplantation. 2003 Apr 15;75(7):1012-9. doi: 10.1097/01.TP.0000057239.32192.B9. Transplantation. 2003. PMID: 12698090 Clinical Trial.

6

In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytomegalovirus infection with ganciclovir in transplant recipients.

Gerna G, Sarasini A, Lilleri D, Percivalle E, Torsellini M, Baldanti F, Revello MG. Gerna G, et al. Among authors: lilleri d. J Infect Dis. 2003 Dec 1;188(11):1639-47. doi: 10.1086/379376. Epub 2003 Nov 14. J Infect Dis. 2003. PMID: 14639533

7

Human cytomegalovirus double resistance in a donor-positive/recipient-negative lung transplant patient with an impaired CD4-mediated specific immune response.

Baldanti F, Lilleri D, Campanini G, Comolli G, Ridolfo AL, Rusconi S, Gerna G. Baldanti F, et al. Among authors: lilleri d. J Antimicrob Chemother. 2004 Mar;53(3):536-9. doi: 10.1093/jac/dkh065. Epub 2004 Jan 22. J Antimicrob Chemother. 2004. PMID: 14739146

8

Monitoring of human cytomegalovirus (HCMV)-specific CD4+ T cell frequency by cytokine flow cytometry as a possible indicator for discontinuation of HCMV secondary prophylaxis in HAART-treated AIDS patients.

Lilleri D, Piccinini G, Genini E, Comolli G, Chiesa A, Tordato F, Sotgiu G, Parisi A, Baldanti F, Revello MG, Gerna G. Lilleri D, et al. J Clin Virol. 2004 Apr;29(4):297-307. doi: 10.1016/S1386-6532(03)00214-2. J Clin Virol. 2004. PMID: 15018859

9

Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients.

Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S, Torsellini M, Gerna G. Lilleri D, et al. J Med Virol. 2004 Jul;73(3):412-8. doi: 10.1002/jmv.20107. J Med Virol. 2004. PMID: 15170637

10

Dendritic-cell infection by human cytomegalovirus is restricted to strains carrying functional UL131-128 genes and mediates efficient viral antigen presentation to CD8+ T cells.

Gerna G, Percivalle E, Lilleri D, Lozza L, Fornara C, Hahn G, Baldanti F, Revello MG. Gerna G, et al. Among authors: lilleri d. J Gen Virol. 2005 Feb;86(Pt 2):275-284. doi: 10.1099/vir.0.80474-0. J Gen Virol. 2005. PMID: 15659746

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page